Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Paulina Gorzelak‐Pabiś"'
Autor:
Ewelina Woźniak, Marlena Broncel, Agnieszka Woźniak, Joanna Satała, Agnieszka Pawlos, Bożena Bukowska, Paulina Gorzelak-Pabiś
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Heterozygous familial hypercholesterolemia (HeFH) is a common autosomal-dominant inherited disorder associated with atherosclerotic cardiovascular disease (ASCVD). HeFH subjects have a higher lipoprotein(a), i.e. Lp(a), concentration than th
Externí odkaz:
https://doaj.org/article/107dcd07ae654cc39806ab8eafdd483e
Autor:
Ewelina Woźniak, Marlena Broncel, Mateusz Niedzielski, Agnieszka Woźniak, Paulina Gorzelak-Pabiś
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0280741 (2023)
Atherosclerosis and cardiovascular events can be prevented, or treated, using statin therapy, either alone or in combination with ezetimibe. Chronic inflammation, vascular proliferation, and the development of atherosclerosis are also influenced by 2
Externí odkaz:
https://doaj.org/article/da01d1f7b2214a3eade3587a17ada62f
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background Lipoprotein (a)–Lp(a) has proinflammatory, prothrombotic and proatherogenic properties and may theoretically influence the course of COVID-19. Objectives The aim of the study was to explore whether patients hospitalized due to COVID-19 w
Externí odkaz:
https://doaj.org/article/64d0635f1ccb46bc80c1ff855da0330a
Autor:
Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak, Łukasz Markiewicz, Agnieszka Piastowska-Ciesielska, Paulina Gorzelak-Pabiś
Publikováno v:
Molecules, Vol 28, Iss 3, p 1112 (2023)
SGLT2 (Sodium-glucose Cotransporter-2) inhibitors are newer glucose-lowering drugs with many cardiovascular benefits that are not fully understood yet. Endothelial integrity plays a key role in cardiovascular homeostasis. 25-hydroxycholesterol (25-OH
Externí odkaz:
https://doaj.org/article/f3ca534689f04956b893d40403a6e093
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0256996 (2021)
Dyslipidemia, atherosclerosis, and cardiovascular events can be prevented, or treated, using statins, alone or in combination with ezetimibe. The aim of the study was to compare the direct pleiotropic effects of two commonly-used statins (atorvastati
Externí odkaz:
https://doaj.org/article/c175955ef4cd41948e3a340361c22c17
Autor:
Agnieszka Pawlos, Marlena Broncel, Ewelina Wlazłowska, Elżbieta Jabłonowska, Paulina Gorzelak-Pabiś
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244675 (2020)
BackgroundHIV patients are at increased cardiovascular risk while available European cardiovascular recommendations are ambiguous.MethodsRetrospective analysis of 389 HIV-patients was conducted. Cardiovascular risk was determined by D:A:D, Framingham
Externí odkaz:
https://doaj.org/article/40d9c6b6747f46a4bd1483f5c38b19c9
Publikováno v:
Molecules, Vol 26, Iss 23, p 7213 (2021)
Patients with diabetes are at higher risk of cardiovascular diseases and cognitive impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin, Sotagliflozin) are newer hypoglycemic agents with many pleiotropic effects. I
Externí odkaz:
https://doaj.org/article/b4c676d711244ad1a40aa1f918f5f4bd
Publikováno v:
Studia Medyczne, Vol 33, Iss 3, Pp 227-231 (2017)
Acquired haemophilia A is rare, autoimmune bleeding disorder caused by the production of autoantibodies against coagulation factor VIII (FVIII). The disorder affects 1.5 people per 1 million population a year, particularly the elderly. Unlike congeni
Externí odkaz:
https://doaj.org/article/ee9fb1425777409ab70e6afafd6ebb48
Autor:
Magdalena Świstek, Marlena Broncel, Paulina Gorzelak-Pabiś, Przemysław Morawski, Mateusz Fabiś, Ewelina Woźniak
Publikováno v:
Endocrine Practice. 28:494-501
The prevalence of euthyroid sick syndrome (ESS) and its association with the prognosis of COVID-19 and mortality in patients with lung involvement in COVID-19 have not yet been elucidated.Clinical and laboratory data of patients with COVID-19 with or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7392ed3661a23797794f974f97513e2c
https://doi.org/10.1016/j.eprac.2022.02.006
https://doi.org/10.1016/j.eprac.2022.02.006
Autor:
Mateusz Fabiś, Paulina Gorzelak-Pabiś, Joanna Satała, Agnieszka Pawlos, Jarosław Fabiś, Marlena Broncel
Publikováno v:
Polish Archives of Internal Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4f83a473dfdb8711304993ec079b81
https://doi.org/10.20452/pamw.16348
https://doi.org/10.20452/pamw.16348